Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Baillies, a human resources specialist based in Milwaukee, Wisconsin, has been attempting to lose weight and dealing with chronic autoimmune issues for years, so she turned to a cheaper alternative: a ...

Many Americans have turned to compounding pharmacies to get popular weight-loss drugs due to lack of availability or expensive retail price tags. But this option will soon close for consumers. The ...

The runaway popularity of GLP-1 medications like Ozempic and Wegovy for weight loss and diabetes management led to a nationwide shortage that lasted more than a year—and created the perfect conditions ...

Whether it’s due to an ingredient allergy or other reasons, compounding pharmacies can help tailor a custom-made medication to meet your needs. And when drug shortages happen, they can play an ...

The US Food and Drug Administration (FDA) recently issued warning letters to more than 40 compounding pharmacies, demanding that they cease certain advertising practices for a variety of compounded ...

Compounded semaglutide is a medication that’s custom-made by a compounding pharmacy. It contains the active ingredient semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist.

CEO Mike Doustdar shared the figure Monday at the J.P. Morgan Healthcare Conference, saying compounded versions have gained ...

Novo Nordisk CEO Mike Doustdar highlighted the growing use of compounded GLP-1 drugs in the U.S., which are cheaper but ...

Compounding is the act of mixing, combining, or altering ingredients to tailor a medication to an individual’s needs. Generally, compounding a medication is done by a licensed pharmacist, a licensed ...